National Human Genome Research Institute; Notice of Closed Meeting, 68639 [2023-21889]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices
VII. Agency Contacts
1. Questions on the programmatic
issues may be directed to:
Applicant’s Area Diabetes Consultant:
https://www.ihs.gov/diabetes/aboutus/area-diabetes-consultants-adc/,
IHS Division of Diabetes Treatment
and Prevention, 5600 Fishers Lane,
Mailstop: 08N34A, Rockville, MD
20857, Phone: (844) 447–3387, Fax:
(301) 594–6213, Email:
diabetesprogram@ihs.gov and sdpi@
ihs.gov, Division of Diabetes website:
https://www.ihs.gov/diabetes/ and
https://www.ihs.gov/sdpi/
2. Questions on awards management
and fiscal matters may be directed to:
Indian Health Service, Division of
Grants Management, 5600 Fishers
Lane, Mail Stop: 09E70, Rockville,
MD 20857, Email: DGM@ihs.gov.
3. For technical assistance with
Grants.gov, please contact the
Grants.gov help desk at (800) 518–4726,
or by email at support@grants.gov.
4. For technical assistance with
GrantSolutions, please contact the
GrantSolutions help desk at (866) 577–
0771, or by email at help@
grantsolutions.gov.
VIII. Other Information
The Public Health Service strongly
encourages all grant, cooperative
agreement, and contract recipients to
provide a smoke-free workplace and
promote the non-use of all tobacco
products. In addition, Public Law 103–
227, the Pro-Children Act of 1994,
prohibits smoking in certain facilities
(or in some cases, any portion of the
facility) in which regular or routine
education, library, day care, health care,
or early childhood development
services are provided to children. This
is consistent with the HHS mission to
protect and advance the physical and
mental health of the American people.
BILLING CODE 4166–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
lotter on DSK11XQN23PROD with NOTICES1
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
20:21 Oct 03, 2023
Jkt 262001
Dated: September 28, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–21974 Filed 10–3–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: September 29, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; High Quality Reference Genomes
(HQRG).
Date: November 29, 2023.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, MSC 6908, Bethesda, MD
20892, (301) 402–8739, pozzattr@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
[FR Doc. 2023–22045 Filed 10–3–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Cancer Institute; Amended
Notice of Meeting
[FR Doc. 2023–22057 Filed 10–3–23; 8:45 am]
partially closed to closed. Due to
scheduling difficulties, there will no
longer be an open session of the
meeting. The meeting is closed to the
public.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Developing Digital Therapeutics for
Substance Use Disorders.
Date: November 14, 2023.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jenny Raye Browning,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Research, National Institute on Drug Abuse,
NIH, 301 North Stonestreet Avenue, MSC
6021, Bethesda, MD 20892, (301) 443–4577,
jenny.browning@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
National Institutes of Health
Roselyn Tso,
Director, Indian Health Service.
VerDate Sep<11>2014
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
68639
Notice is hereby given of a change in
the meeting of the Board of Scientific
Counselors, National Cancer Institute,
November 13, 2023, 10 a.m. to
November 14, 2023, 1:45 p.m., National
Institute of Health, Building 31, C Wing,
6th Floor, Conference Room C, 9000
Rockville Pike, Bethesda, MD 20892,
which was published in the Federal
Register on September 28, 2023, FR Doc
2023–21147, 88 FR 66861.
This meeting notice is being amended
to change the meeting type from
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: September 28, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–21889 Filed 10–3–23; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\04OCN1.SGM
04OCN1
]]>Agencies
[Federal Register Volume 88, Number 191 (Wednesday, October 4, 2023)]
[Notices]
[Page 68639]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21889]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; High Quality Reference Genomes (HQRG).
Date: November 29, 2023.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Human Genome Research
Institute, National Institutes of Health, 6700B Rockledge Drive, MSC
6908, Bethesda, MD 20892, (301) 402-8739, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: September 28, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-21889 Filed 10-3-23; 8:45 am]
BILLING CODE 4140-01-P
